Glucoregulatory, endocrine and morphological effects of [P5K]hymenochirin-1B in mice with diet-induced glucose intolerance and insulin resistance

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  2016-04-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00210-016-1243-5PMID 27068334
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review

  2016influential reference
• Repurposing Drugs to Target the Diabetes Epidemic.

  2016cited by this paper
• An extract of Urtica dioica L. mitigates obesity induced insulin resistance in mice skeletal muscle via protein phosphatase 2A (PP2A)

  2016cited by this paper
• In vitro and in vivo insulinotropic properties of the multifunctional frog skin peptide hymenochirin-1B: a structure–activity study

  2015influential reference
• Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  2015influential reference
• The frog skin host-defense peptide CPF-SE1 improves glucose tolerance, insulin sensitivity and islet function and decreases plasma lipids in high-fat fed mice.

  2015cited by this paper
• Beneficial effects of tigerinin-1R on glucose homeostasis and beta cell function in mice with diet-induced obesity-diabetes.

  2015cited by this paper
• Oleic and linoleic fatty acids downregulate Slc2a4/GLUT4 expression via NFKB and SREBP1 in skeletal muscle cells.

  2015cited by this paper
• Positive effects of GLP‐1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes

  2015cited by this paper
• Magainin-AM2 improves glucose homeostasis and beta cell function in high-fat fed mice.

  2015cited by this paper
• Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies

  2015cited by this paper
• Alterations of Pancreatic Islet Structure, Metabolism and Gene Expression in Diet-Induced Obese C57BL/6J Mice

  2014cited by this paper
• Insulin Resistance Alters Islet Morphology in Nondiabetic Humans

  2014cited by this paper
• Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents.

  2014influential reference
• Incretin Receptor Null Mice Reveal Key Role of GLP-1 but Not GIP in Pancreatic Beta Cell Adaptation to Pregnancy

  2014cited by this paper
• High fat diet and GLP-1 drugs induce pancreatic injury in mice.

  2014cited by this paper
• Frog skin peptides (tigerinin-1R, magainin-AM1, -AM2, CPF-AM1, and PGla-AM1) stimulate secretion of glucagon-like peptide 1 (GLP-1) by GLUTag cells.

  2013cited by this paper
• Beta Cell Dysfunction and Insulin Resistance

  2013cited by this paper
• An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties.

  2013cited by this paper
• Alterations of Glucose-Dependent Insulinotropic Polypeptide and Expression of Genes Involved in Mammary Gland and Adipose Tissue Lipid Metabolism during Pregnancy and Lactation

  2013cited by this paper
• Do GLP-1–Based Therapies Increase Cancer Risk?

  2013cited by this paper
• Anti-tumor activities of the host-defense peptide hymenochirin-1B.

  2013cited by this paper
• Mechanisms of insulin resistance in obesity

  2013cited by this paper
• GLP1 and cancer: friend or foe?

  2012cited by this paper
• Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.

  2012cited by this paper
• The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).

  2012cited by this paper
• A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function

  2012cited by this paper
• Case report of acute necrotizing pancreatitis associated with combination treatment of sitagliptin and exenatide.

  2012cited by this paper
• Degradation, insulin secretion, glucose-lowering and GIP additive actions of a palmitate-derivatised analogue of xenin-25.

  2012cited by this paper
• Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

  2011cited by this paper
• Incretin effect: GLP-1, GIP, DPP4.

  2011cited by this paper
• Acute Pancreatitis in Type 2 Diabetes Treated With Exenatide or Sitagliptin

  2010cited by this paper
• Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans.

  2009influential reference
• Analysis of gene expression in pancreatic islets from diet-induced obese mice.

  2008cited by this paper
• Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors.

  2007cited by this paper
• Impairment of the insulinotropic effect of gastric inhibitory polypeptide (GIP) in obese and diabetic rats is related to the down-regulation of its pancreatic receptors.

  2007cited by this paper
• Mechanisms linking obesity to insulin resistance and type 2 diabetes

  2006cited by this paper
• The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes.

  2004cited by this paper
• Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid.

  2003cited by this paper
• Dietary fat and the development of type 2 diabetes.

  2002cited by this paper
• Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis.

  1997cited by this paper
• An improved method for isolation of mouse pancreatic islets.

  1985influential reference
• Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice

  1981cited by this paper

• Beneficial effect of animal skin-derived bioactive peptides on type 2 diabetes mellitus: A review on preparation, structure-activity relationship, and blood glucose regulation mechanism.

  2026cites this paper
• Comorbidity Genes of Alzheimer’s Disease and Type 2 Diabetes Associated with Memory and Cognitive Function

  2024cites this paper
• Venom Peptides, Polyphenols and Alkaloids: Are They the Next Antidiabetics That Will Preserve β-Cell Mass and Function in Type 2 Diabetes?

  2023cites this paper
• Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities.

  2020cites this paper
• A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice.

  2020cites this paper
• Drug Delivery Strategies for Enhancing the Therapeutic Efficacy of Toxin-Derived Anti-Diabetic Peptides

  2020cites this paper
• Mechanisms of action of the anti-diabetic peptide [S4K]CPF-AM1 in db/db mice.

  2020cites this paper
• Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: a mechanistic study.

  2020cites this paper
• Conformational change following conversion of inactive rhinophrynin-33 to bioactive rhinophrynin-27 in the skin of the frog Rhinophrynus dorsalis.

  2020cites this paper
• Peptidomic analysis in the discovery of therapeutically valuable peptides in amphibian skin secretions

  2019cites this paper
• Stapling strategy enables improvement of antitumor activity and proteolytic stability of host-defense peptide hymenochirin-1B

  2018cites this paper
• Identification of Components in Frog Skin Secretions with Therapeutic Potential as Antidiabetic Agents.

  2018cites this paper
• Characterization of an insulinotropic peptide from skin secretions of Odorrana andersonii

  2017cites this paper
• Cytotoxic peptides with insulin‐releasing activities from skin secretions of the Italian stream frog Rana italica (Ranidae)

  2017cites this paper
• Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome

  2017cites this paper
• Peptides from frog skin with potential for development into agents for Type 2 diabetes therapy

  2017cites this paper